Literature DB >> 12430891

The diagnosis from the pathological viewpoint of a blood disease.

Masafumi Ito1.   

Abstract

The histopathological viewpoints of a blood diseases are namely following the cytological examinations except for the viewpoint of organ pathology and has been required only the usefulness in case with the difficulty of cytological examination. If it looks at a blood disease as hematopoietic organ disease, histopathological diagnostic study might make the new paradigm of blood diseases. In this time, I would like to present the hematological diagnosis from the pathological viewpoint by using histological bone marrow sections. *How to examine the bone marrow histology *Hematopoietic microenvironment disorder *Differential diagnosis of hypoplastic marrow lesions *Clinicopathological characteristics of Hypoplastic leukemia *Hemophagocytosis in bone marrow *How to diagnose MDS by histopathology. Bone marrow histology is the valuable diagnostic tool of many kinds of marrow disorders especial cases. By using immunohistochemistry and Giemsa staining, further information might obtain than smear film cytology. Bone marrow clot section aspirated from sternum is enough for histological examination except bone marrow biopsy. Precise cytomorphology might demonstrate by smear film than section histology. However surface phenotype would define by flow cytometric analysis, immunostaining of sections could demonstrate which cells show which markers. Structural and architectural disorder could only be represent by histology. The histological examination of bone marrow might introduce a new aspects of blood disease.

Entities:  

Mesh:

Year:  2002        PMID: 12430891     DOI: 10.1007/bf03165076

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  4 in total

1.  Hemoglobin F synthesis is not restricted to fetal erythropoietic organs during extramedullary hematopoiesis.

Authors:  Jong Weon Choi; Yonggoo Kim; Masahiko Fujino; Masafumi Ito
Journal:  Haematologica       Date:  2002-03       Impact factor: 9.941

2.  F-blast is a useful marker for differentiating hypocellular refractory anemia from aplastic anemia.

Authors:  Jong Weon Choi; Masahiko Fujino; Masafumi Ito
Journal:  Int J Hematol       Date:  2002-04       Impact factor: 2.490

3.  A new anti-hemoglobin F antibody against synthetic peptides for the detection of F-cell precursors (F-blasts) in bone marrow.

Authors:  J W Choi; Y Kim; M Fujino; M Ito
Journal:  Int J Hematol       Date:  2001-10       Impact factor: 2.490

4.  Significance of fetal hemoglobin-containing erythroblasts (F blasts) and the F blast/F cell ratio in myelodysplastic syndromes.

Authors:  J W Choi; Y Kim; M Fujino; M Ito
Journal:  Leukemia       Date:  2002-08       Impact factor: 11.528

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.